132 related articles for article (PubMed ID: 36497442)
21. B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and classical hodgkin lymphoma: diagnosis by fine-needle aspiration cytology.
Lynnhtun K; Varikatt W; Pathmanathan N
Diagn Cytopathol; 2014 Aug; 42(8):690-3. PubMed ID: 23630122
[TBL] [Abstract][Full Text] [Related]
22. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms.
Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H
Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109
[TBL] [Abstract][Full Text] [Related]
23. Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
Zeng Q; Gupta A; Xin L; Poon M; Schwarz H
J Hematol; 2019 Jun; 8(2):47-54. PubMed ID: 32300443
[TBL] [Abstract][Full Text] [Related]
24. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
Wang L; Wang W; Li X; Guo Y; Zhu X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
[TBL] [Abstract][Full Text] [Related]
25. A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma.
Sylvain C
Expert Rev Hematol; 2022 Mar; 15(3):195-201. PubMed ID: 35318887
[TBL] [Abstract][Full Text] [Related]
26. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide.
Wen KW; Fakhri B; Menke J; Ruiz-Cordero R; Gill RM; Ohgami RS
Ann Diagn Pathol; 2020 Jun; 46():151534. PubMed ID: 32473554
[TBL] [Abstract][Full Text] [Related]
27. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
Jiang S; Zhen H; Jiang H
Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP; Fedoriw Y; Weiss LM
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
[TBL] [Abstract][Full Text] [Related]
29. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
30. Livin, a novel marker in lymphoma type distinction.
Tanhaei AP; Ziaei A; Mazrouei S; Keyhanian K; Salehi M
Ann Diagn Pathol; 2014 Jun; 18(3):157-62. PubMed ID: 24767895
[TBL] [Abstract][Full Text] [Related]
31. Correlations between baseline
Decazes P; Camus V; Bohers E; Viailly PJ; Tilly H; Ruminy P; Viennot M; Hapdey S; Gardin I; Becker S; Vera P; Jardin F
EJNMMI Res; 2020 Oct; 10(1):120. PubMed ID: 33029662
[TBL] [Abstract][Full Text] [Related]
32. Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patient.
Thomas RK; Wickenhauser C; Kube D; Tesch H; Diehl V; Wolf J; Vockerodt M
Leuk Lymphoma; 2004 May; 45(5):1065-9. PubMed ID: 15291369
[TBL] [Abstract][Full Text] [Related]
33. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.
Gion Y; Doi M; Nishimura Y; Ikeda T; Filiz Nishimura M; Sakamoto M; Egusa Y; Nishikori A; Fujita A; Iwaki N; Nakamura N; Yoshino T; Sato Y
Cancer Med; 2022 Jan; 11(2):417-432. PubMed ID: 34842351
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Gion Y; Iwaki N; Takata K; Takeuchi M; Nishida K; Orita Y; Tachibana T; Yoshino T; Sato Y
Cancer Sci; 2017 Jun; 108(6):1271-1280. PubMed ID: 28380678
[TBL] [Abstract][Full Text] [Related]
36. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
37. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
38. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
[TBL] [Abstract][Full Text] [Related]
39. A case of primary gastric diffuse large B-cell lymphoma occurring in chronic myeloid leukemia.
Cai Z; Liu S; Zi J; Ma J; Ge Z
Onco Targets Ther; 2019; 12():5917-5923. PubMed ID: 31413589
[TBL] [Abstract][Full Text] [Related]
40. Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.
Chen YT; Chadburn A; Lee P; Hsu M; Ritter E; Chiu A; Gnjatic S; Pfreundschuh M; Knowles DM; Old LJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3093-8. PubMed ID: 20133697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
